Press release
North America Diabetes Care Drugs Market Trends, Research Report, Growth, Opportunities, Forecast 2020-2026
North America diabetes care drugs market is anticipated to grow significantly over the forecast period (2020-2026). The US and Canada are the two major economies contributing to the growth of the market. The key factor that drives the growth of the North American diabetes care drug industry includes the increased prevalence of diabetes across the region.According to IDF (International Diabetes Federation), in 2019, the prevalence of diabetes was around 13.3% of the total adult population in the region which is expected to increase up to 14.2% by 2030 and 15% by 2045. Thus, the increased prevalence of diabetes will create demand for diabetes drugs and thus provides growth opportunities for the market in the forecast period.
(Get 15% Discount on Buying this Report)
A full report of North America Diabetes Care Drugs Market is available at: https://www.omrglobal.com/industry-reports/north-american-diabetes-care-drugs-market
Further, the presence of the key players such as Bayer AG, Bausch Health Companies Inc., Bristol Myers Squibb Co., Eli Lilly and Co., Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., among others also contributes to the growth of the market. These players adopt several growth strategies such as product launches, mergers and acquisitions, product innovations, and others. For instance, in February 2020, Sun Pharmaceutical Industries through its wholly-owned subsidiary launched Riomet ER, used to treat type 2 diabetes mellitus, in the US market. Riomet ER is the first and only US FDA-approved liquid formulation of extended-release metformin.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-diabetes-care-drugs-market
Market Coverage
• Market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segment Covered- By Drug Class
• Region Covered- North America
• Competitive Landscape- Bausch Health Companies Inc., Bristol Myers Squibb Co., Eli Lilly and Co., Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Pfizer Inc., and Takeda Pharmaceuticals Industries Ltd.
Key questions addressed by the report
• What is the market growth rate?
• Which segment region dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
North America Diabetes Care Drugs Market – Segmentation
By Drug Class
• Insulins
• Non-Insulin Injectable Drugs
• Oral Anti-Diabetic Drugs
• Combination Drugs
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/north-american-diabetes-care-drugs-market
North America Diabetes Care Drugs Market – Countries Covered
• US
• Canada
Company Profiles
• AstraZeneca Plc
• Bayer AG
• Bausch Health Companies Inc.
• Boehringer Ingelheim International GmbH
• Bristol Myers Squibb Co.
• Eli Lilly and Co.
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• Mylan NV
• Nectar Therapeutics
• Novartis International AG
• Novo Nordisk A/S
• Pfizer Inc.
• Sanofi SA
• Sun Pharmaceutical Industries Ltd.
• Takeda Pharmaceuticals Industries Ltd.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America Diabetes Care Drugs Market Trends, Research Report, Growth, Opportunities, Forecast 2020-2026 here
News-ID: 2266517 • Views: …
More Releases from Orion Market Research
Hard Tea Market Set to Witness Significant Growth by 2033 | Two Chicks Cocktails …
The global Hard Tea Market was valued at approximately USD 2.81 billion in 2024, and is expected to reach around USD 20.34 billion by 2033, growing at a robust compound annual growth rate (CAGR) of 24.6% from 2025 to 2033.
Hard Tea Market Overview
The Hard Tea Market is experiencing explosive growth as consumers seek refreshing, lower-calorie alcoholic beverages with familiar tea flavors-positioning hard tea as a key player in the…
Polyethylene Terephthalate (PET) Market: Emerging Trends and Growth Forecast to …
The global Polyethylene Terephthalate (PET) market was valued at approximately USD 79.0 billion in 2023 and is projected to reach around USD 143.7 billion by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2033.
Polyethylene Terephthalate (PET) Market Overview
The Polyethylene Terephthalate (PET) market is experiencing significant growth, driven by its widespread use in packaging, textiles, and consumer goods. PET's recyclability and lightweight properties make…
Pharmaceuticals Market Overview: Growth, Share, Value, Size, and Scope
The global pharmaceutical market was valued at approximately USD 1.5 trillion in 2023 and is projected to reach around USD 2.7 trillion by 2033, growing at a compound annual growth rate (CAGR) of 6.11% from 2024 to 2033.
Pharmaceuticals Market Overview
The global pharmaceutical market is experiencing steady growth, driven by factors such as the increasing prevalence of chronic diseases, an aging population, and advancements in medical research. Conventional drugs, particularly…
Urethral Dilators Market Set to Witness Significant Growth by 2033 | Medline Ind …
The Urethral Dilators Market was valued at approximately USD 251.1 million in 2024, and is anticipated to reach USD 387.1 million by 2033, representing a compound annual growth rate (CAGR) of 4.92% from 2025 to 2033.
Urethral Dilators Market Overview
The Urethral Dilators Market is experiencing moderate yet consistent growth, supported largely by increasing incidences of urological conditions like urethral strictures and kidney stones. Minimally invasive procedures are increasingly preferred by both…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
